TY - JOUR
T1 - Differentiation and activation of human CD4 T cells is associated with a gradual loss of myelin and lymphocyte protein
AU - Leitner, Judith
AU - Mahasongkram, Kodchakorn
AU - Schatzlmaier, Philipp
AU - Pfisterer, Karin
AU - Leksa, Vladimir
AU - Pata, Supansa
AU - Kasinrerk, Watchara
AU - Stockinger, Hannes
AU - Steinberger, Peter
N1 - Publisher Copyright:
© 2021 The Authors. European Journal of Immunology published by Wiley-VCH GmbH
PY - 2021/4
Y1 - 2021/4
N2 - Upon generation of monoclonal antibodies to the T cell antigen receptor/CD3 (TCR/CD3) complex, we isolated mAb MT3, whose reactivity correlates inversely with the production of IFN-γ by human peripheral blood T lymphocytes. Using eukaryotic expression cloning, we identified the MT3 antigen as myelin-and-lymphocyte (MAL) protein. Flow cytometry analysis demonstrates high surface expression of MAL on all naïve CD4+ T cells whereas MAL expression is diminished on central memory- and almost lost on effector memory T cells. MAL- T cells proliferate strongly in response to stimulation with CD3/CD28 antibodies, corroborating that MAL+ T cells are naïve and MAL- T cells memory subtypes. Further, resting MAL- T cells harbor a larger pool of Ser59- and Tyr394- double phosphorylated lymphocyte-specific kinase (Lck), which is rapidly increased upon in vitro restimulation. Previously, lack of MAL was reported to prevent transport of Lck, the key protein tyrosine kinase of TCR/CD3 signaling to the cell membrane, and to result in strongly impaired human T cell activation. Here, we show that knocking out MAL did not significantly affect Lck membrane localization and immune synapse recruitment, or transcriptional T cell activation. Collectively, our results indicate that loss of MAL is associated with activation-induced differentiation of human T cells but not with impaired membrane localization of Lck or TCR signaling capacity.
AB - Upon generation of monoclonal antibodies to the T cell antigen receptor/CD3 (TCR/CD3) complex, we isolated mAb MT3, whose reactivity correlates inversely with the production of IFN-γ by human peripheral blood T lymphocytes. Using eukaryotic expression cloning, we identified the MT3 antigen as myelin-and-lymphocyte (MAL) protein. Flow cytometry analysis demonstrates high surface expression of MAL on all naïve CD4+ T cells whereas MAL expression is diminished on central memory- and almost lost on effector memory T cells. MAL- T cells proliferate strongly in response to stimulation with CD3/CD28 antibodies, corroborating that MAL+ T cells are naïve and MAL- T cells memory subtypes. Further, resting MAL- T cells harbor a larger pool of Ser59- and Tyr394- double phosphorylated lymphocyte-specific kinase (Lck), which is rapidly increased upon in vitro restimulation. Previously, lack of MAL was reported to prevent transport of Lck, the key protein tyrosine kinase of TCR/CD3 signaling to the cell membrane, and to result in strongly impaired human T cell activation. Here, we show that knocking out MAL did not significantly affect Lck membrane localization and immune synapse recruitment, or transcriptional T cell activation. Collectively, our results indicate that loss of MAL is associated with activation-induced differentiation of human T cells but not with impaired membrane localization of Lck or TCR signaling capacity.
KW - Animals
KW - CD28 Antigens/immunology
KW - CD3 Complex/immunology
KW - CD4-Positive T-Lymphocytes/cytology
KW - Cell Differentiation/genetics
KW - Cell Line, Tumor
KW - Flow Cytometry
KW - Gene Expression/immunology
KW - Humans
KW - Interferon-gamma/immunology
KW - Jurkat Cells
KW - Lymphocyte Activation/genetics
KW - Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/genetics
KW - Mice
KW - Myelin and Lymphocyte-Associated Proteolipid Proteins/genetics
KW - Phosphorylation
KW - Receptors, Antigen, T-Cell/genetics
KW - Reverse Transcriptase Polymerase Chain Reaction
KW - Signal Transduction/genetics
KW - Tumor Necrosis Factor-alpha/immunology
UR - http://www.scopus.com/inward/record.url?scp=85099772229&partnerID=8YFLogxK
U2 - 10.1002/eji.202048603
DO - 10.1002/eji.202048603
M3 - Journal article
C2 - 33345332
SN - 0014-2980
VL - 51
SP - 848
EP - 863
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 4
ER -